Thallium-201 brain SPECT to diagnose aggressiveness of meningiomas.
This investigation was conducted to determine the ability of 201Tl brain SPECT with respect to preoperative prediction of lesional aggressiveness of meningioma. Fifty-nine lesions in 42 patients were examined. Early (15 min) and late (3 h) SPECT were obtained. Early uptake ratio (ER; lesion to normal brain average count ratio), late uptake ratio (LR) and the ratio of LR to ER (L/E ratio) were calculated. Twenty-three lesions exhibited malignant features based on histologic or clinical course such as recurrence or skull invasion. Both ER and LR of malignant meningiomas were significantly higher than those in thirty-six benign lesions. Benign lesions were classified into two groups for further analysis: meningotheliomatous type, which is the most common histology, and benign lesions other than the meningotheliomatous (other benign) type. ER in other benign type was lower than the meningotheliomatous and the malignant type. LR afforded differentiation of the malignant type from the two benign types. These two benign types could be distinguished on the basis of the L/E ratio. These results indicate that high pre-operative ER and LR values in patients with meningioma are indicators of the aggressiveness of lesions, i.e., malignant meningioma, recurrence or skull invasion.
Kinuya
Keiko
K
Department of Nuclear Medicine, Tonami General Hospital, Toyama, Japan. dinky@d9.dion.ne.jp
Ohashi
Masahiro
M
Itoh
Syotaro
S
Sakai
Sohtaro
S
Yamamoto
Kenji
K
Kakuda
Kiyoshi
K
Nobata
Koji
K
Terahata
Shintaro
S
Taki
Suzuka
S
Kinuya
Seigo
S
D001932:Brain Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D005240:Feasibility Studies; D006801:Humans; D008577:Meningeal Neoplasms / Q000145:classification / Q000000981:diagnostic imaging* / Q000473:pathology; D008579:Meningioma / Q000145:classification / Q000000981:diagnostic imaging* / Q000473:pathology; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000000981:diagnostic imaging; D009367:Neoplasm Staging / Q000379:methods; D019275:Radiopharmaceuticals; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013793:Thallium; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*
D019275:Radiopharmaceuticals; C027549:thallium chloride; D013793:Thallium